Literature DB >> 8859077

Age-related macular degeneration and smoking. The Rotterdam Study.

J R Vingerling1, A Hofman, D E Grobbee, P T de Jong.   

Abstract

OBJECTIVE: To assess the relation between cigarette smoking and age-related macular degeneration (AMD) in a population of elderly persons.
DESIGN: A cross-sectional, community-based study.
SETTING: City district of Rotterdam, the Netherlands. PARTICIPANTS: A total of 6174 persons 55 years and older who participated in the Rotterdam Study. In 36 persons atrophic AMD and in 65 persons neovascular AMD were diagnosed. MAIN OUTCOME MEASURES: Age-related macular degeneration was diagnosed by evaluating fundus transparencies, smoking behavior was identified by interviewing subjects, and the presence of atherosclerosis was assessed by the ankle-arm systolic blood pressure index. Relative risks and 95% confidence intervals (CIs) were calculated using multivariate logistic regression analysis.
RESULTS: In subjects younger than 85 years, current smokers had a 6.6-fold increased risk of neovascular AMD vs those who had never smoked (95% CI, 2.8-15.9). Former smokers had a 3.2-fold increased risk of neovascular AMD vs nonsmokers in this age group (95% CI, 1.4-7.4). These associations were not observed in subjects 85 years or older. Smoking was not associated with atrophic AMD. A strong increased risk of neovascular AMD was present in those who had smoked more than 10 pack-years (relative risk, 6.5; 95% CI, 2.9-14.8). Adjusting the results for atherosclerosis did not change the association. Persons who had quit smoking 20 or more years before the eye examination had no increased risk.
CONCLUSIONS: The results provide evidence for a dose-response relationship between smoking and AMD, particularly in persons with the neovascular form of the disease.

Entities:  

Mesh:

Year:  1996        PMID: 8859077     DOI: 10.1001/archopht.1996.01100140393005

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  75 in total

1.  Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration?

Authors:  O Ishida; H Oku; T Ikeda; M Nishimura; K Kawagoe; K Nakamura
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

2.  Tobacco: a medical history.

Authors:  R Doll
Journal:  J Urban Health       Date:  1999-09       Impact factor: 3.671

Review 3.  Epidemiology of age-related maculopathy: a review.

Authors:  Redmer van Leeuwen; Caroline C W Klaver; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

4.  Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions.

Authors:  Daniel E Weeks; Yvette P Conley; Hui-Ju Tsai; Tammy S Mah; Silke Schmidt; Eric A Postel; Anita Agarwal; Jonathan L Haines; Margaret A Pericak-Vance; Philip J Rosenfeld; T Otis Paul; Andrew W Eller; Lawrence S Morse; J P Dailey; Robert E Ferrell; Michael B Gorin
Journal:  Am J Hum Genet       Date:  2004-05-27       Impact factor: 11.025

5.  Smoking and blindness.

Authors:  Simon P Kelly; Judith Thornton; Georgios Lyratzopoulos; Richard Edwards; Paul Mitchell
Journal:  BMJ       Date:  2004-03-06

Review 6.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

Review 7.  Seeing into the future. Vision and aging.

Authors:  R E Kalina
Journal:  West J Med       Date:  1997-10

8.  HTRA1 variants in exudative age-related macular degeneration and interactions with smoking and CFH.

Authors:  Pancy O S Tam; Tsz Kin Ng; David T L Liu; Wai Man Chan; Sylvia W Y Chiang; Li Jia Chen; Andrew DeWan; Josephine Hoh; Dennis S C Lam; Chi Pui Pang
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-03       Impact factor: 4.799

9.  Oxidative stress induces mitochondrial dysfunction and a protective unfolded protein response in RPE cells.

Authors:  Marisol Cano; Lei Wang; Jun Wan; Bradley P Barnett; Katayoon Ebrahimi; Jiang Qian; James T Handa
Journal:  Free Radic Biol Med       Date:  2014-01-14       Impact factor: 7.376

Review 10.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.